title: Addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis.
authors.forename: H Jorn
authors.initials: HJ
authors.lastname: Bovenschen
authors.forename: Wil-Janne
authors.initials: WJ
authors.lastname: Gerritsen
authors.forename: Elke M G J
authors.initials: EM
authors.lastname: de Jong
authors.forename: Peter C M
authors.initials: PC
authors.lastname: van de Kerkhof
mesh_terms: D000279:Administration, Cutaneous; D000077944:Alefacept; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001623:Betamethasone / Q000008:administration & dosage*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D006801:Humans; D007273:Injections, Intramuscular; D011446:Prospective Studies; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage*; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D011993:Recombinant Fusion Proteins; D001623:Betamethasone; D000077944:Alefacept